Publication | Closed Access

The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant

Risk AssessmentThrombosisThrombopoiesisVenous ThrombosisAutoimmune DiseaseCardiovascular DiseaseBlood PlateletLupusAnti-prothrombin AntibodiesHematologyImmunologyCoagulopathyPublic HealthMedicineAnticoagulantAtherosclerosisEpidemiologyClinical Significance